ASS1 and Hyperammonemia: Concordantly, in brains of CTLN1 mice, we observed fewer astrocytes based on Gfap expression levels and a reduced number GFAP positive cells, as observed in brains of rats with acute hyperammonemia [44] and hepatic encephalopathy in humans [45].